<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00872053</url>
  </required_header>
  <id_info>
    <org_study_id>B4125K-1</org_study_id>
    <nct_id>NCT00872053</nct_id>
  </id_info>
  <brief_title>Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis</brief_title>
  <official_title>Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to:&#xD;
&#xD;
        1. Collect pilot data on the effect of task-specific lower extremity training using the&#xD;
           Anklebot on subjects with Multiple Sclerosis (MS) and who have foot drop;&#xD;
&#xD;
        2. Collect pilot data on the use of combination therapy on improving gait in subjects with&#xD;
           MS. This therapy will use both Anklebot training and robot-assisted gait training.&#xD;
&#xD;
      Hypothesis: Both trainings will result in improved walking performance, but the combination&#xD;
      therapy will result in greater gains than ankle training alone.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ankle accuracy and stiffness</measure>
    <time_frame>At inclusion, after 8 sessions, after 16 sessions</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gait assessments (e.g., 6-Minute Walk, Timed 25-Foot Walk)</measure>
    <time_frame>At inclusion, after every 4 sessions</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional assessments (EDSS, MS Functional Composite)</measure>
    <time_frame>At inclusion, after 8 sessions, after 16 sessions</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>MS (Multiple Sclerosis)</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Focused Ankle Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anklebot</intervention_name>
    <description>The Anklebot is a robotic device that is worn via a leather boot and knee brace (Fig.1). As the participant goes through a series of ankle-training &quot;games,&quot; the Anklebot can assist ankle movement throughout 3 planes.</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lokomat</intervention_name>
    <description>The Lokomat is a motor driven exoskeleton device that employs a body weight support suspension system and treadmill. Attached to the lower limbs, the Lokomat moves the subject's legs over a treadmill through position controlled trajectories that mimic normal human gait patterns.</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of MS by McDonald criteria (McDonald, Compston et al. 2001). EDSS&#xD;
             level between 3.5-5.5, who report ambulation problems.&#xD;
&#xD;
          -  Presence of unilateral foot drop that is clinically apparent to the PI or PI&#xD;
             designate.&#xD;
&#xD;
          -  Must be able to ambulate 25 feet without an assisting device.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cardiovascular: recent MI &lt; 4 wk, uncontrolled HTN &gt;190/110 mmHg.&#xD;
&#xD;
          -  History of uncontrolled diabetes.&#xD;
&#xD;
          -  Symptoms of orthostasis when standing up.&#xD;
&#xD;
          -  Circulatory problems, history of vascular claudication or pitting edema.&#xD;
&#xD;
          -  Unable to fully understand instructions in order to use the equipment or the process&#xD;
             of the study.&#xD;
&#xD;
          -  Body weight over 150 kg.&#xD;
&#xD;
          -  Lower extremity injuries that limit range of motion or function.&#xD;
&#xD;
          -  Joint problems (hip or leg) that limit range of motion or cause pain with movement&#xD;
             despite treatment.&#xD;
&#xD;
          -  Unstable fractures.&#xD;
&#xD;
          -  Pressure sores with any skin breakdown in areas in contact with the body harness or&#xD;
             Lokomat apparatus.&#xD;
&#xD;
          -  Chronic and ongoing alcohol or drug abuse.&#xD;
&#xD;
          -  Pre-morbid, ongoing depression or psychosis.&#xD;
&#xD;
          -  Ongoing physical therapy.&#xD;
&#xD;
          -  Pregnancy (self-reported)&#xD;
&#xD;
          -  PI's determination of inability to complete the test protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert Lo, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Providence VA Medical Center</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908-4799</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <study_first_submitted>March 27, 2009</study_first_submitted>
  <study_first_submitted_qc>March 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2009</study_first_posted>
  <last_update_submitted>September 18, 2013</last_update_submitted>
  <last_update_submitted_qc>September 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>robot</keyword>
  <keyword>treadmill</keyword>
  <keyword>foot drop</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>gait</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Peroneal Neuropathies</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>November 12, 2013</submitted>
    <returned>January 2, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

